Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04665245 · ClinicalTrials.gov registry record
Symptom-Based Markers for COVID-19 Transmission
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 214
- Enrollment target
NCT04665245: Completed study, sponsored by University of Iowa.
NCT04665245 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 214 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04665245 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 214 participants
- Enrollment target
Study Summary
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.
Primary Outcome
Body temperature taken each morning and evening throughout COVID-19 infection period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2021-05-19 |
What the finished NCT04665245 record still lists
NCT04665245 is an observational study that tracks outcomes without assigning an intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04665245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04665245 about?
NCT04665245 is a clinical study titled "Symptom-Based Markers for COVID-19 Transmission". In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at...
What is the current status of trial NCT04665245?
This trial is currently completed. The enrollment target is 214 participants. The study started on 2020-12-15. Estimated completion is 2021-05-19.
Who is sponsoring clinical trial NCT04665245?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI